Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-20-000310
Filing Date
2020-07-14
Accepted
2020-07-14 16:09:31
Documents
41
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 06-30-2020 form_10-q.htm 10-Q 632247
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5676
3 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3576
4 GRAPHIC angiosoma-logo.jpg GRAPHIC 12338
  Complete submission text file 0001161697-20-000310.txt   2236580

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE soan-20200630.xml EX-101.INS 336923
6 XBRL SCHEMA FILE soan-20200630.xsd EX-101.SCH 18647
7 XBRL CALCULATION FILE soan-20200630_cal.xml EX-101.CAL 30506
8 XBRL DEFINITION FILE soan-20200630_def.xml EX-101.DEF 98235
9 XBRL LABEL FILE soan-20200630_lab.xml EX-101.LAB 152566
10 XBRL PRESENTATION FILE soan-20200630_pre.xml EX-101.PRE 135307
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 201027268
SIC: 2834 Pharmaceutical Preparations